References
- Shields CL, Mashayekhi A, Au AK, et al. The international classification of retinoblastoma predicts chemoreduction success. Ophthalmology. December 2006;113(12):2276–2280. doi:10.1016/j.ophtha.2006.06.018.
- Abramson DH, Dunkel IJ, Brodie SE, Marr B, Gobin YP. Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery). Ophthalmology. August 2010;117(8):1623–1629. doi:10.1016/j.ophtha.2009.12.030.
- Shields CL, Manjandavida FP, Lally SE, et al. Intra-arterial chemotherapy for retinoblastoma in 70 eyes: outcomes based on the international classification of retinoblastoma. Ophthalmology. July 2014;121(7):1453–1460. doi:10.1016/j.ophtha.2014.01.026.
- Francis JH, Abramson DH, Gaillard MC, Marr BP, Beck-Popovic M, Munier FL. The classification of vitreous seeds in retinoblastoma and response to intravitreal melphalan. Ophthalmology. June 2015;122(6):1173–1179. doi:10.1016/j.ophtha.2015.01.017.
- Francis JH, Brodie SE, Marr B, Zabor EC, Mondesire-Crump I, Abramson DH. Efficacy and Toxicity of intravitreous chemotherapy for retinoblastoma: four-year experience. Ophthalmology. April 2017;124(4):488–495. doi:10.1016/j.ophtha.2016.12.015.
- Sigler EJ, Randolph JC, Calzada JI, Wilson MW, Haik BG. Current management of Coats’ disease. Surv Ophthalmol. January-February 2014;59(1):30–46. doi:10.1016/j.survophthal.2013.03.007.
- Zahavi A, Weinberger D, Snir M, Ron Y. Management of severe persistent fetal vasculature: case series and review of the literature. Int Ophthalmol. February 23, 2018. doi:10.1007/s10792-018-0855-9.
- van Ravenswaaij-Arts C, Martin DM. New insights and advances in CHARGE syndrome: diagnosis, etiologies, treatments, and research discoveries. Am J Med Genet C Semin Med Genet. December 2017;174(4):397–406. doi:10.1002/ajmg.c.31592.
- Gilmour DF. Familial exudative vitreoretinopathy and related retinopathies. Eye (Lond). January 2015;29(1):1–14. doi:10.1038/eye.2014.70.
- Pefkianaki M, Hasanreisoglu M, Suchy SF, Shields CL. Familial exudative vitreoretinopathy with a novel LRP5 mutation. J Pediatr Ophthalmol Strabismus. July 30, 2016;53:e39–42. doi:10.3928/01913913-20160719-02.